Applying Computational Fluid Dynamics Technology in Bioprocesses-Part 2 - Computational fluid dynamics can resolve performance problems. - BioPharm International

ADVERTISEMENT

Applying Computational Fluid Dynamics Technology in Bioprocesses-Part 2
Computational fluid dynamics can resolve performance problems.


BioPharm International
Volume 23, Issue 5

56. Hristov HV, Mann R, Lossev V, Vlaev SD, Seichter P. A 3-D analysis of gas-liquid mixng, mass transfer and bioreaction in a stirred bioreactor. Trans Inst Chem Eng. 2001;79:232–41.

57. Xu B, Jahic M, Enfors SO. Modelling of overflow metabolism in batch and fed-batch cultures of Escherichia coli. Biotechnol Prog. 1999;15:81–90.

58. Smith MW, Neeidhardt FC. Proteins induced by anaerobiosis in Escherichia coli. J Bacteriol. 1983;154:336–43.

59. Dhanasekharan KM, Sanyal J, Jain A, Haidari A. A generalized approach to model oxygen transfer in bioreactors using population balances and computational fluid dynamics. Chem Eng Sci. 2005;60(1):213–8.

60. Bajpai PK, Reuss M. Coupling of mixing and microbial kinetics for evaluating the performance of bioreactors. Can J Chem Eng. 1982;60:384–92.

61. Reuss M, Schmalzriedt S, Jenne M. Application of computational fluid dynamics (CFD) to modeling stirred-tank bioreactors. In: Schugerl K, Bellgardt KH, editors. Bioreaction Engineering Modeling and Control. Berlin: Springer; 2000.

62. Larsson G, Törnkvist M, Wernersson ES, Trägårdh C, Noorman H, Enfors SO. Substrate gradients in bioreactors: origin and consequences. Bioproc Biosys Eng. 1996;14(6):281–9.

63. Ma N, Mollet M, Chalmers JJ. Aeration, mixing and hydrodynamics in bioreactors. In: Ozturk SS, Hu WS, editor. Cell culture technology for pharmaceutical and cell-based therapies. New York, London: 2006; Taylor & Francis.

64. Wu J. Mechanisms of animal cell damage associated with gas bubbles and cell protection by medium additives. J Biotechnol. 1995;43(2):81–94.

65. Chisti Y. Animal-cell damage in sparged bioreactors. Trends in biotechnology. 2000 Oct 18;(10):420–32.

66. Jöbses I, Martens D, Tramper J. Lethal events during gas sparging in animal cell culture. Biotech Bioeng. 1991;37(5):484–90.

67. Murhammer DW, Goochee CF. Sparged animal cell bioreactors: mechanism of cell damage and Pluronic F-68 protection. Biotechnol Prog. 1990;6(5):391–7.

68. Garcia-Briones M, Chalmers JJ. Cell-bubble interactions. Mechanisms of suspended cell damage. Ann New York Acad Sci. 1992;665:219–29.

69. Chattopadhyay D, Rathman JF, Chalmers JJ. The protective effect of specific medium additives with respect to bubble rupture. Biotech Bioeng. 1995;45(6):473–80.

70. Meier SJ, Hatton A, Wang DI. Cell death from bursting bubbles: Role of cell attachment to rising bubbles in sparged reactors. Biotech Bioeng. 1998;62(4):468–78.

71. Koynov A, Tryggvason G, Khinast JG. Characterization of the localized hydrodynamic shear forces and dissolved oxygen distribution in sparged bioreactors. Biotech Bioeng. 2007;97(2):317–31.

72. Schaffer M, Yianneskis M, Wachter P, Durst F. Trailing vortices around a 45° pitched-blade impeller. AIChE J. 1998;44(5):1233–46.

73. Maa Y-F, Hsu CC. Effect of high shear on proteins. Biotech Bioeng. 1996;51(4):458–65.

74. Maa Y-F, Hsu CC. Protein denaturation by combined effect of shear and air-liquid interface. Biotech Bioeng. 1997;54(6):503–12.

75. Kioukia N, Nienow AW, Emery AN, Al-Rubeai M. The impact of fluid dynamics on the biological performance of free suspension animal cell culture: Further studies. Trans Inst Chem Eng Part C. 1992;70:143–7.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here